Ashleigh Barreto Email

Head Investor Relations & Corporate Communications . Viracta Therapeutics (formerly Sunesis)

Cardiff-by-the-Sea, CA

Location

Current Roles

Employees:
52
Revenue:
$5.9M
About
Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
Viracta Therapeutics (formerly Sunesis) Address
2533 S. Coast Hwy 101
Cardiff-by-the-Sea, CA
United States
Viracta Therapeutics (formerly Sunesis) Email
Viracta Therapeutics (formerly Sunesis) Phone Numbers
858-400-8470

Past Companies

Viracta Therapeutics, Inc.Head of Investor Relations & Corporate Communications
Ziopharm OncologyDirector, Investor Relations and Corporate Communications
BioMarin Pharmaceutical Inc.Associate Director, Investor Relations

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.